Sources | Names Used |
---|---|
CTRPv2 | navitoclax:PLX-4032 (1:1 mol/mol) |
PharmacoGx | navitoclax:PLX-4032 (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ZNF730 | CTRPv2 | pan-cancer | AAC | 0.15 | 5e-05 |
mRNA | C1orf56 | CTRPv2 | pan-cancer | AAC | -0.15 | 5e-05 |
mRNA | TBCB | CTRPv2 | pan-cancer | AAC | 0.15 | 5e-05 |
mRNA | ABLIM2 | CTRPv2 | pan-cancer | AAC | 0.14 | 5e-05 |
mRNA | GNAZ | CTRPv2 | pan-cancer | AAC | 0.14 | 5e-05 |
mRNA | DTNA | CTRPv2 | pan-cancer | AAC | 0.14 | 5e-05 |
mRNA | CCDC30 | CTRPv2 | pan-cancer | AAC | 0.14 | 5e-05 |
mRNA | BRD1 | CTRPv2 | pan-cancer | AAC | 0.15 | 5e-05 |
mRNA | NEGR1 | CTRPv2 | pan-cancer | AAC | 0.14 | 5e-05 |
mRNA | TSTD3 | CTRPv2 | pan-cancer | AAC | -0.14 | 5e-05 |